You are here: Industry Insights > Moderna

News List

Moderna will not enforce COVID-19 vaccine patents during pandemic expresspharma
October 09, 2020
Moderna is not asserting its intellectual property rights for its vaccine technology.
Moderna and Vertex partner on gene-editing therapies for cystic fibrosis pharmaceutical-technology
September 18, 2020
Moderna has teamed up with Vertex Pharmaceuticals to identify and develop lipid nanoparticles (LNPs) and messenger RNAs (mRNAs) for the delivery of gene-editing therapies to treat cystic fibrosis (CF).
Moderna would seek EUA in US for COVID-19 vaccine based on early data expresspharma
September 18, 2020
If the interim readout is deemed by the independent safety committee as positive with 70 or 80 or 90 per cent efficacy, we will indeed consider approval, said company CEO.
Clinical Trial of AstraZeneca COVID-19 Vaccine Paused After Illness drugs.com
September 10, 2020
A "potentially unexplained" illness in a participant has led AstraZeneca to halt a late-stage clinical trial of its COVID-19 vaccine.
COVID-19 vaccine makers to prepare joint pledge for safety expresspharma
September 07, 2020
The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes.
Moderna informs COVID-19 vaccine induced immune response in older adults in small study expresspharma
August 27, 2020
The latest data from an early Phase I study includes an analysis from 20 additional people detailing how the vaccine performed in older adults.
40 per cent participants enrolled for COVID-19 vaccine trial: Moderna expresspharma
August 24, 2020
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September.
Moderna Announces COVID-19 Vaccine Supply Agreement with U.S. Government americanpharmaceuticalreview
August 19, 2020
Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people.
US signs $1.5 bn deal with Moderna for 100 mn doses of COVID-19 vaccine expresspharma
August 12, 2020
Moderna’s deal with the US only pays out in full if the company hits certain unspecific timing benchmarks for vaccine delivery.
Canada signs deals with Pfizer, Moderna for supply of COVID-19 vaccines expresspharma
August 07, 2020
Moderna to provide its mRNA-1273 vaccine candidate while Pfizer- BioNTech to supply their BNT162 mRNA-based vaccine candidate.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 22 23 Next page